HEADER HYDROLASE 04-JUL-15 5A7G TITLE COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND TITLE 2 AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIVER CARBOXYLESTERASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 21-552; COMPND 5 SYNONYM: ACYL-COENZYME A- CHOLESTEROL ACYLTRANSFERASE, ACAT, BRAIN COMPND 6 CARBOXYLESTERASE HBR1, CARBOXYLESTERASE 1, CE-1, HCE-1, COCAINE COMPND 7 CARBOXYLESTERASE, EGASYN, HMSE, METHYLUMBELLIFERYL-ACETATE COMPND 8 DEACETYLASE 1, MONOCYTE/MACROPHAGE SERINE ESTERASE, RETINYL ESTER COMPND 9 HYDROLASE, REH, SERINE ESTERASE 1, TRIACYLGLYCEROL HYDROLASE, TGH, COMPND 10 CARBOXYLESTERASE 1; COMPND 11 EC: 3.1.1.1, 3.1.1.56; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: HEK 323; SOURCE 6 ATCC: CRL-1573; SOURCE 7 ORGAN: LIVER; SOURCE 8 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 9 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM_CELL_LINE: HEK 323; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: POPINTTG KEYWDS HYDROLASE, ESTERASE EXPDTA X-RAY DIFFRACTION AUTHOR V.ARENA DE SOUZA,D.J.SCOTT,M.CHARLTON,M.A.WALSH,R.J.OWEN REVDAT 4 10-JAN-24 5A7G 1 HETSYN REVDAT 3 29-JUL-20 5A7G 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 15-MAY-19 5A7G 1 REMARK LINK REVDAT 1 13-JAN-16 5A7G 0 JRNL AUTH V.ARENA DE SOUZA,D.J.SCOTT,J.E.NETTLESHIP,N.RAHMAN, JRNL AUTH 2 M.H.CHARLTON,M.A.WALSH,R.J.OWENS JRNL TITL COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND JRNL TITL 2 AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1. JRNL REF PLOS ONE V. 10 43919 2015 JRNL REFN ESSN 1932-6203 JRNL PMID 26657071 JRNL DOI 10.1371/JOURNAL.PONE.0143919 REMARK 2 REMARK 2 RESOLUTION. 1.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 93337 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.131 REMARK 3 R VALUE (WORKING SET) : 0.129 REMARK 3 FREE R VALUE : 0.173 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4985 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.48 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.52 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5418 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.49 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 286 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4107 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 695 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.16000 REMARK 3 B22 (A**2) : 0.16000 REMARK 3 B33 (A**2) : -0.53000 REMARK 3 B12 (A**2) : 0.16000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.062 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.061 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.052 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.316 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.984 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.974 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4242 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4083 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5764 ; 1.510 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9430 ; 0.924 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 531 ; 8.568 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 173 ;32.301 ;24.740 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 717 ;11.853 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;15.897 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 641 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4749 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 924 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2118 ; 3.367 ; 2.669 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2117 ; 3.365 ; 2.667 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2645 ; 4.113 ; 4.023 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2646 ; 4.113 ; 4.024 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2124 ; 4.298 ; 3.051 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2124 ; 4.299 ; 3.051 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3118 ; 4.958 ; 4.414 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5461 ; 6.440 ;24.443 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5058 ; 5.633 ;22.752 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 8325 ; 3.589 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 186 ;65.490 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 8725 ;24.361 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 5A7G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1290064284. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : SI111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 104388 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.480 REMARK 200 RESOLUTION RANGE LOW (A) : 53.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.69000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 5A7F REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN AT 4C IN 0.1 M REMARK 280 BICINE/TRIZMA BASE, PH 8.5, CONTAINING 0.03 M EACH OF DIETHYLENE REMARK 280 GLYCOL, TRIETHYLENE GLYCOL, TETRAETHYLENE GLYCOL, PENTAETHYLENE REMARK 280 GLYCOL, 10 % (W/V) PEG 4000, 20 % (V/V) GLYCEROL, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 57.69500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 33.31022 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 42.71333 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 57.69500 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 33.31022 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.71333 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 57.69500 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 33.31022 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 42.71333 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 66.62045 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 85.42667 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 66.62045 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 85.42667 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 66.62045 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 85.42667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2695 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 315 REMARK 465 GLN A 316 REMARK 465 PRO A 317 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2126 O HOH A 2128 2.00 REMARK 500 O HOH A 2003 O HOH A 2017 2.06 REMARK 500 SG CYS A 389 O HOH A 2519 2.09 REMARK 500 O HOH A 2114 O HOH A 2115 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 76 -148.13 64.41 REMARK 500 ALA A 80 60.56 -115.26 REMARK 500 SER A 185 82.45 -157.50 REMARK 500 ALA A 221 -118.26 64.81 REMARK 500 THR A 252 90.66 -69.65 REMARK 500 TRP A 357 -59.60 -153.26 REMARK 500 PHE A 425 -59.25 -122.91 REMARK 500 ASN A 520 -153.62 -109.36 REMARK 500 LYS A 539 26.74 49.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG A 339 ASN A 340 137.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2024 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH A2067 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A2163 DISTANCE = 7.52 ANGSTROMS REMARK 525 HOH A2243 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A2262 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A2469 DISTANCE = 6.32 ANGSTROMS REMARK 525 HOH A2470 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH A2506 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH A2513 DISTANCE = 6.51 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5A7F RELATED DB: PDB REMARK 900 COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND REMARK 900 AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1 REMARK 900 RELATED ID: 5A7H RELATED DB: PDB REMARK 900 COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND REMARK 900 AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SITE MUTATION S221A DISORDERED RESIDUES 315-317 DBREF 5A7G A 21 552 UNP P23141 EST1_HUMAN 21 553 SEQADV 5A7G ALA A 221 UNP P23141 SER 221 ENGINEERED MUTATION SEQRES 1 A 532 SER SER PRO PRO VAL VAL ASP THR VAL HIS GLY LYS VAL SEQRES 2 A 532 LEU GLY LYS PHE VAL SER LEU GLU GLY PHE ALA GLN PRO SEQRES 3 A 532 VAL ALA ILE PHE LEU GLY ILE PRO PHE ALA LYS PRO PRO SEQRES 4 A 532 LEU GLY PRO LEU ARG PHE THR PRO PRO GLN PRO ALA GLU SEQRES 5 A 532 PRO TRP SER PHE VAL LYS ASN ALA THR SER TYR PRO PRO SEQRES 6 A 532 MET CYS THR GLN ASP PRO LYS ALA GLY GLN LEU LEU SER SEQRES 7 A 532 GLU LEU PHE THR ASN ARG LYS GLU ASN ILE PRO LEU LYS SEQRES 8 A 532 LEU SER GLU ASP CYS LEU TYR LEU ASN ILE TYR THR PRO SEQRES 9 A 532 ALA ASP LEU THR LYS LYS ASN ARG LEU PRO VAL MET VAL SEQRES 10 A 532 TRP ILE HIS GLY GLY GLY LEU MET VAL GLY ALA ALA SER SEQRES 11 A 532 THR TYR ASP GLY LEU ALA LEU ALA ALA HIS GLU ASN VAL SEQRES 12 A 532 VAL VAL VAL THR ILE GLN TYR ARG LEU GLY ILE TRP GLY SEQRES 13 A 532 PHE PHE SER THR GLY ASP GLU HIS SER ARG GLY ASN TRP SEQRES 14 A 532 GLY HIS LEU ASP GLN VAL ALA ALA LEU ARG TRP VAL GLN SEQRES 15 A 532 ASP ASN ILE ALA SER PHE GLY GLY ASN PRO GLY SER VAL SEQRES 16 A 532 THR ILE PHE GLY GLU ALA ALA GLY GLY GLU SER VAL SER SEQRES 17 A 532 VAL LEU VAL LEU SER PRO LEU ALA LYS ASN LEU PHE HIS SEQRES 18 A 532 ARG ALA ILE SER GLU SER GLY VAL ALA LEU THR SER VAL SEQRES 19 A 532 LEU VAL LYS LYS GLY ASP VAL LYS PRO LEU ALA GLU GLN SEQRES 20 A 532 ILE ALA ILE THR ALA GLY CYS LYS THR THR THR SER ALA SEQRES 21 A 532 VAL MET VAL HIS CYS LEU ARG GLN LYS THR GLU GLU GLU SEQRES 22 A 532 LEU LEU GLU THR THR LEU LYS MET LYS PHE LEU SER LEU SEQRES 23 A 532 ASP LEU GLN GLY ASP PRO ARG GLU SER GLN PRO LEU LEU SEQRES 24 A 532 GLY THR VAL ILE ASP GLY MET LEU LEU LEU LYS THR PRO SEQRES 25 A 532 GLU GLU LEU GLN ALA GLU ARG ASN PHE HIS THR VAL PRO SEQRES 26 A 532 TYR MET VAL GLY ILE ASN LYS GLN GLU PHE GLY TRP LEU SEQRES 27 A 532 ILE PRO MET LEU MET SER TYR PRO LEU SER GLU GLY GLN SEQRES 28 A 532 LEU ASP GLN LYS THR ALA MET SER LEU LEU TRP LYS SER SEQRES 29 A 532 TYR PRO LEU VAL CYS ILE ALA LYS GLU LEU ILE PRO GLU SEQRES 30 A 532 ALA THR GLU LYS TYR LEU GLY GLY THR ASP ASP THR VAL SEQRES 31 A 532 LYS LYS LYS ASP LEU PHE LEU ASP LEU ILE ALA ASP VAL SEQRES 32 A 532 MET PHE GLY VAL PRO SER VAL ILE VAL ALA ARG ASN HIS SEQRES 33 A 532 ARG ASP ALA GLY ALA PRO THR TYR MET TYR GLU PHE GLN SEQRES 34 A 532 TYR ARG PRO SER PHE SER SER ASP MET LYS PRO LYS THR SEQRES 35 A 532 VAL ILE GLY ASP HIS GLY ASP GLU LEU PHE SER VAL PHE SEQRES 36 A 532 GLY ALA PRO PHE LEU LYS GLU GLY ALA SER GLU GLU GLU SEQRES 37 A 532 ILE ARG LEU SER LYS MET VAL MET LYS PHE TRP ALA ASN SEQRES 38 A 532 PHE ALA ARG ASN GLY ASN PRO ASN GLY GLU GLY LEU PRO SEQRES 39 A 532 HIS TRP PRO GLU TYR ASN GLN LYS GLU GLY TYR LEU GLN SEQRES 40 A 532 ILE GLY ALA ASN THR GLN ALA ALA GLN LYS LEU LYS ASP SEQRES 41 A 532 LYS GLU VAL ALA PHE TRP THR ASN LEU PHE ALA LYS MODRES 5A7G ASN A 79 ASN GLYCOSYLATION SITE HET NAG A1553 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 HOH *695(H2 O) HELIX 1 1 LEU A 60 ARG A 64 5 5 HELIX 2 2 ASP A 90 THR A 102 1 13 HELIX 3 3 ALA A 148 TYR A 152 5 5 HELIX 4 4 GLY A 154 ASN A 162 1 9 HELIX 5 5 LEU A 172 PHE A 178 1 7 HELIX 6 6 ASN A 188 ILE A 205 1 18 HELIX 7 7 ALA A 206 PHE A 208 5 3 HELIX 8 8 ALA A 221 LEU A 232 1 12 HELIX 9 9 SER A 233 LYS A 237 5 5 HELIX 10 10 THR A 252 VAL A 254 5 3 HELIX 11 11 VAL A 261 GLY A 273 1 13 HELIX 12 12 THR A 278 LYS A 289 1 12 HELIX 13 13 THR A 290 LYS A 302 1 13 HELIX 14 14 THR A 331 ARG A 339 1 9 HELIX 15 15 TRP A 357 MET A 363 1 7 HELIX 16 16 ASP A 373 SER A 384 1 12 HELIX 17 17 SER A 384 CYS A 389 1 6 HELIX 18 18 ALA A 391 GLU A 393 5 3 HELIX 19 19 LEU A 394 GLY A 404 1 11 HELIX 20 20 ASP A 408 PHE A 425 1 18 HELIX 21 21 PHE A 425 ALA A 439 1 15 HELIX 22 22 GLU A 470 PHE A 475 1 6 HELIX 23 23 GLY A 476 LEU A 480 5 5 HELIX 24 24 SER A 485 GLY A 506 1 22 HELIX 25 25 LYS A 539 ALA A 551 1 13 SHEET 1 AA 3 VAL A 25 THR A 28 0 SHEET 2 AA 3 GLY A 31 LEU A 34 -1 O GLY A 31 N THR A 28 SHEET 3 AA 3 VAL A 77 ASN A 79 1 O LYS A 78 N LEU A 34 SHEET 1 AB11 LYS A 36 VAL A 38 0 SHEET 2 AB11 VAL A 47 PRO A 54 -1 O VAL A 47 N VAL A 38 SHEET 3 AB11 TYR A 118 THR A 123 -1 O LEU A 119 N ILE A 53 SHEET 4 AB11 VAL A 164 ILE A 168 -1 O VAL A 165 N TYR A 122 SHEET 5 AB11 LEU A 133 ILE A 139 1 O PRO A 134 N VAL A 164 SHEET 6 AB11 GLY A 210 GLU A 220 1 N ASN A 211 O LEU A 133 SHEET 7 AB11 ARG A 242 GLU A 246 1 O ARG A 242 N ILE A 217 SHEET 8 AB11 TYR A 346 ASN A 351 1 O MET A 347 N SER A 245 SHEET 9 AB11 THR A 443 GLN A 449 1 O TYR A 444 N VAL A 348 SHEET 10 AB11 GLY A 524 GLY A 529 1 O LEU A 526 N GLU A 447 SHEET 11 AB11 GLN A 533 GLN A 536 -1 O GLN A 533 N GLN A 527 SHEET 1 AC 2 MET A 86 CYS A 87 0 SHEET 2 AC 2 LEU A 112 SER A 113 1 N SER A 113 O MET A 86 SHEET 1 AD 2 VAL A 256 LYS A 257 0 SHEET 2 AD 2 THR A 321 VAL A 322 1 O THR A 321 N LYS A 257 SSBOND 1 CYS A 87 CYS A 116 1555 1555 2.02 SSBOND 2 CYS A 274 CYS A 285 1555 1555 2.07 LINK ND2 ASN A 79 C1 NAG A1553 1555 1555 1.46 CRYST1 115.390 115.390 128.140 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008666 0.005003 0.000000 0.00000 SCALE2 0.000000 0.010007 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007804 0.00000